Interferon α 2b Pharmacovigilance Study

Clinical trial NCT01841775 · COMPLETED

Trial details

NCT number: NCT01841775
Sponsor: The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Hepatitis C, Chronic

Start date: 2009-05-01
Primary completion: 2012-09-01
Enrollment: 85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.